Sebaceous carcinoma: an immunohistochemical reappraisal
- PMID: 21778832
- DOI: 10.1097/DAD.0b013e31820a2027
Sebaceous carcinoma: an immunohistochemical reappraisal
Abstract
The rates of distant metastases and tumor death in sebaceous carcinoma (SC) have been reported to be higher than those of other cutaneous carcinomas, such as squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), regardless of whether they occur in ocular or extraocular regions. Therefore, strict differentiation of SC from SCC and BCC is required. In this article, we report immunohistochemical findings of SC and compare these data to those of SCC, BCC, and sebaceoma. An immunohistochemical study was performed using 7 antibodies [anti-carcinoembryonic antigen (CEA), anti-epithelial membrane antigen (EMA), anti-CA15-3, anti-CA19-9, anti-androgen receptor (AR), anti-epithelial antigen (Ber-EP4), and anti-adipophilin (ADP)] on 35 cases of SC (16 cases in ocular and 19 cases in extraocular regions) and 10 cases of each SCC (5 cases in ocular and 5 cases in extraocular regions), BCC (5 cases in ocular and 5 cases in extraocular regions), and sebaceoma (no cases arose on the eyelids). In summary, the typical immunophenotypes of SC were EMA+, CA15-3+, AR+, Ber-EP4-, and ADP+; those of sebaceoma were CEA-, EMA+, Ber-EP4-, and ADP+; those of SCC were CEA-, EMA+, CA19-9-, AR-, Ber-EP4-, and ADP-; and those of BCC were CEA-, EMA-, CA15-3-, Ber-EP4+, and ADP-. Other antibody tests for each neoplasm were positive in about half of the cases. The detection of AR and ADP was useful for differentiating SC from SCC, whereas the determination of EMA, CA15-3, Ber-EP4, and ADP was valuable in differentiating SC from BCC.
Similar articles
-
Immunohistochemistry in ocular carcinomas.J Cutan Pathol. 2008 Jul;35(7):641-6. doi: 10.1111/j.1600-0560.2007.00871.x. Epub 2008 Jan 14. J Cutan Pathol. 2008. PMID: 18201230
-
Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.Histopathology. 2007 Jul;51(1):80-6. doi: 10.1111/j.1365-2559.2007.02722.x. Histopathology. 2007. PMID: 17593083
-
Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.Am J Dermatopathol. 2015 Nov;37(11):809-21. doi: 10.1097/DAD.0000000000000255. Am J Dermatopathol. 2015. PMID: 26485238
-
Sebaceous Carcinoma of the Eyelid.Cancer Control. 2016 Apr;23(2):126-32. doi: 10.1177/107327481602300206. Cancer Control. 2016. PMID: 27218789 Review.
-
Practical immunohistochemistry of epithelial skin tumor.Indian J Dermatol Venereol Leprol. 2012 Nov-Dec;78(6):698-708. doi: 10.4103/0378-6323.102359. Indian J Dermatol Venereol Leprol. 2012. PMID: 23075638 Review.
Cited by
-
Sebaceous Neoplasms.Diagnostics (Basel). 2023 May 9;13(10):1676. doi: 10.3390/diagnostics13101676. Diagnostics (Basel). 2023. PMID: 37238164 Free PMC article. Review.
-
Aggressive extraocular sebaceous carcinoma recurring after mohs micrographic surgery.Case Rep Oncol Med. 2015;2015:534176. doi: 10.1155/2015/534176. Epub 2015 Jan 22. Case Rep Oncol Med. 2015. PMID: 25685571 Free PMC article.
-
External auditory canal sebaceous carcinoma.BMJ Case Rep. 2023 Sep 29;16(9):e255038. doi: 10.1136/bcr-2023-255038. BMJ Case Rep. 2023. PMID: 37775279 Free PMC article.
-
Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality.Radiol Oncol. 2016 Jul 19;50(3):308-12. doi: 10.1515/raon-2016-0039. eCollection 2016 Sep 1. Radiol Oncol. 2016. PMID: 27679547 Free PMC article.
-
Sebaceous carcinoma: an updated review of pathogenesis, diagnosis, and treatment options.Arch Dermatol Res. 2023 Dec 19;316(1):55. doi: 10.1007/s00403-023-02747-7. Arch Dermatol Res. 2023. PMID: 38112896 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials